Focal adhesion kinase (FAK) as a central protein of FAs promotes FA turnover and cell migration and stabilization of FAs by FAK inhibitors was shown to have anti-tumor effects (Schober et al., 2007; Tiede et al., 2018). The gene discussed is PTK2; the disease is neoplasm.